CoChat

RAS Mutation Prevalence Among Patients With Metastatic Colorectal Cancer: a Meta-Analysis of Real-World Data

Open access
Kafatos, George, Niepel, Daniela, Lowe, Kimberley, Jenkins-Anderson, Sophie, Westhead, Hal, Garawin, Tamer, Traugottová, Zuzana, Bilalis, Antonios, Molnar, Edit, Timar, Jozsef, Toth, Erika, Gouvas, Nikolaos, Papaxoinis, George, Murray, Samuel, Mokhtar, Nadia, Vosmikova, Hana, Fabian, Pavel, Skalova, Alena, Wójcik, Piotr, Tysarowski, Andrzej, Barugel, Mario, van Krieken, J Han, Trojan, Jörg · 2017 · Biomarkers in Medicine
Cited by 47

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

AIM: A confirmed wild-type RAS tumor status is commonly required for prescribing anti-EGFR treatment for metastatic colorectal cancer. This noninterventional, observational research project estimated RAS mutation prevalence from real-world sources. MATERIALS & METHODS: Aggregate RAS mutation data were collected from 12 sources in three regions. Each source was analyzed separately; pooled prevalence estimates were then derived from meta-analyses. RESULTS: The pooled RAS mutation prevalence from 4431 tumor samples tested for RAS mutation status was estimated to be 43.6% (95% CI: 38.8-48.5%); ranging from 33.7% (95% CI: 28.4-39.3%) to 54.1% (95% CI: 51.7-56.5%) between sources. CONCLUSION: The RAS mutation prevalence estimates varied among sources. The reasons for this are not clear and highlight the need for further research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2217/bmm-2016-0358

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Kafatos, G., Niepel, D., Lowe, K., Jenkins-Anderson, S., Westhead, H., Garawin, T., Traugottová, Z., Bilalis, A., Molnar, E., Timar, J., Toth, E., Gouvas, N., Papaxoinis, G., Murray, S., Mokhtar, N., Vosmikova, H., Fabian, P., Skalova, A., Wójcik, P., Tysarowski, A., Barugel, M., van Krieken, J. H., & Trojan, J.
Venue
Biomarkers in Medicine
Published
2017-07-27
Volume
11
Issue
9
Pages
751-760
ISSN
  • 1752-0363 (ISSN-L)
  • 1752-0371
OpenAlex
W2591370630
Cited by
47
References
5
FWCI
0.38
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.